Clinical Trial Tracker
Track 73 active clinical trials for peptide compounds with real NCT numbers from ClinicalTrials.gov. Filter by phase, status, compound, or therapeutic area to monitor the clinical development pipeline.
Active and completed clinical trials for peptide compounds — data sourced from ClinicalTrials.gov
Status:
Phase:
Sort:
Pipeline View
Compound
Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Frequently Asked Questions
What clinical trials does this track? +
This tracker monitors 73 active clinical trials for peptide compounds sourced from ClinicalTrials.gov, the NIH/NLM registry. Trials cover GLP-1 agonists (semaglutide, tirzepatide, retatrutide), recovery peptides (BPC-157, TB-500), growth hormone secretagogues, and emerging compounds. Each entry includes the NCT number, phase, enrollment status, therapeutic area, and a direct link to the official trial record.
How often is trial data updated? +
Trial data is reviewed and updated regularly to reflect changes in enrollment status, phase progression, and new trial registrations on ClinicalTrials.gov. Status changes such as trials moving from recruiting to completed, or new Phase 3 expansions, are incorporated as they are published in the federal registry.
Can I search by condition or compound? +
Yes. Use the search bar to find trials by compound name (e.g., semaglutide, BPC-157), NCT number, or condition (e.g., obesity, type 2 diabetes, tendon repair). You can also filter by trial phase (Phase 1 through Phase 4), status (recruiting, active, completed), and therapeutic area. Filters can be combined for precise results.
Data sourced from ClinicalTrials.gov. This tool is for educational and research purposes only.
Trial information may not reflect the most recent updates. Always verify on ClinicalTrials.gov.
Related Tools & Resources